학술논문

The First of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients
Document Type
Article
Source
In: Aesthetic Surgery Journal. (Aesthetic Surgery Journal, 1 December 2021, 41(12):1409-1422)
Subject
Language
English
ISSN
1527330X
1090820X